Corvus Pharmaceuticals’ (CRVS) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Corvus Pharmaceuticals (NASDAQ:CRVS – Free Report) in a research note released on Wednesday,Benzinga reports. They currently have a $11.00 price objective on the stock. Corvus Pharmaceuticals Stock Down 14.8 % Corvus Pharmaceuticals stock opened at $3.35 on Wednesday. The stock has a market cap of $215.26 […]
HC Wainwright reiterated their buy rating on shares of Corvus Pharmaceuticals (NASDAQ:CRVS – Free Report) in a research note released on Wednesday,Benzinga reports. They currently have a $11.00 price objective on the stock. Corvus Pharmaceuticals Stock Down 14.8 % Corvus Pharmaceuticals stock opened at $3.35 on Wednesday. The stock has a market cap of $215.26 […]
